Endogenex has raised US$50m to complete development of its diabetes procedure and take the technology to the FDA. The fundraising...
An NHS diabetes drug costing as little as 2p a tablet could cut prostate cancer risk by more than a third, a study suggests. Metformin is...
MemoryAid, a phone-like device for dementia care, has shown positive trial results and is due to launch to the public this year. Developed by a team...
Vision-restoration company Science Corp has closed a US$230m Series C financing round which will allow it to complete the commercialisation of its brain-computer interface, retinal implant,...
An Alzheimer’s mutation may delay disease onset by about 20 years in people otherwise expected to develop memory loss in their mid-40s. The mutation affects a...
A trial is enrolling men with stress urinary incontinence to test a new implant, after regulators in the US and France cleared the study. Stress urinary...
A daily multivitamin may modestly slow biological ageing over two years, though the effect appears small and any health benefit remains unclear. The study followed 958...
